RxDoctor Payments Data

Benjamin Swartz, MD

Family Medicine · Perrysburg, OHNPI 1033648035

Payments from drug & device makers

$2,879in general payments, 2019–2025

Across 155 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$552
  • Novo Nordisk$302
  • Pfizer$252
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$210
  • Exact Sciences$209
  • Lilly USA, LLC$207
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$2,879100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,879 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$229,818
Medicare patients
463
Services billed
3,863

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide68$105,330
EliquisApixaban97$98,697
JardianceEmpagliflozin99$95,448
JanuviaSitagliptin Phosphate29$48,267
RybelsusSemaglutide26$46,826
XareltoRivaroxaban35$35,230
FarxigaDapagliflozin Propanediol26$29,415
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$23,281
MounjaroTirzepatide11$18,952
Repatha SureclickEvolocumab11$15,672
JanumetSitagliptin Phos/Metformin Hcl16$13,524
LinzessLinaclotide21$12,142
VascepaIcosapent Ethyl14$9,183
Lantus SolostarInsulin Glargine,hum.Rec.Anlog64$8,886
Repatha SyringeEvolocumab16$8,505

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$302$152,15694 claims
PfizerEliquis, Paxlovid$252$101,565123 claims
Boehringer IngelheimJardiance$153$95,44899 claims
AstraZenecaFarxiga$76$29,41526 claims
GSKTrelegy Ellipta, Incruse Ellipta$138$27,14637 claims
Lilly USA, LLCMounjaro$207$18,95211 claims
AbbVieLinzess, Synthroid$552$14,24597 claims
Kowa Pharmaceuticals America, Inc.Livalo$13$4,18612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Perrysburg

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →